Preemptive Infusion of Donor Lymphocytes Depleted of TCR + T Cells + CD19+ B Cells Following ASCT

NCT03939585 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Lack of funding

Conditions

Allogeneic Stem Cell Transplant Candidate
Acute Myeloid/Lymphoblastic Leukemia
Myelodysplastic Syndrome
Myeloproliferative Neoplasm
Lymphoproliferative Disorders

Interventions

BIOLOGICAL: Cellular therapy product

Sponsor

Leland Metheny